Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Quantitative Rationalization of Gemfibrozil Drug Interactions: Consideration of Transporters-Enzyme Interplay and the Role of Circulating Metabolite Gemfibrozil 1-O-β-GlucuronideVarma, Manthena V S ; Lin, Jian ; Bi, Yi-an ; Kimoto, Emi ; Rodrigues, A DavidDrug metabolism and disposition, 2015-07, Vol.43 (7), p.1108-1118 [Periódico revisado por pares]United StatesTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non-gemfibrozil fibrate trialsDoi, Takahito ; Langsted, Anne ; Nordestgaard, Børge GJournal of internal medicine, 2024-05, Vol.295 (5), p.707-710 [Periódico revisado por pares]England: Blackwell Publishing LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Gemfibrozil derivatives as activators of soluble guanylyl cyclase – A structure-activity studyGayler, Kevin M. ; Quintana, Jeremy M. ; Mattke, Jordan ; Plunk, Michael A. ; Kostyo, Jessica H. ; Karunananthan, Johann W. ; Nguyen, Harold ; Shuda, Mina ; Ferreira, Liam D. ; Baker, Hannah ; Stinchcomb, Alexandra L. ; Sharina, Iraida ; Kane, Robert R. ; Martin, EmilEuropean journal of medicinal chemistry, 2021-11, Vol.224, p.113729-113729, Article 113729 [Periódico revisado por pares]France: Elsevier Masson SASTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Gemfibrozil May Decrease Norclozapine Elimination: A Case ReportBarclay, Jaqueline ; McCollum, Betsy ; Schoretsanitis, Georgios ; de Leon, JoseJournal of clinical psychopharmacology, 2019-07, Vol.39 (4), p.405-407 [Periódico revisado por pares]United StatesTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug–Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and GemfibrozilIga, Katsumi ; Kiriyama, AkikoClinical pharmacokinetics, 2024, Vol.63 (1), p.43-56 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Gemfibrozil-Platinum(IV) Precursors for New Enhanced-Starvation and Chemotherapy In Vitro and In VivoSong, Xue-Qing ; Guo, Xu ; Ding, Yi-Xin ; Han, Yi-Xuan ; You, Zhi-Hao ; Song, Yali ; Yuan, Yanan ; Li, LongfeiJournal of medicinal chemistry, 2024-05, Vol.67 (9), p.7033-7047 [Periódico revisado por pares]United States: American Chemical SocietyTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Gemfibrozil, a lipid‐lowering drug, improves hepatorenal damages in a mouse model of agingHakimizadeh, Elham ; Tadayon, Saeedeh ; Zamanian, Mohammad Yasin ; Soltani, Afsaneh ; Giménez‐Llort, Lydia ; Hassanipour, Mahsa ; Fatemi, ImanFundamental & clinical pharmacology, 2023-06, Vol.37 (3), p.599-605 [Periódico revisado por pares]England: Wiley Subscription Services, IncTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Association of plasma metabolites and diagnostic imaging findings with hepatic lipidosis in bearded dragons (Pogona vitticeps) and effects of gemfibrozil therapyBarboza, Trinita K ; Susta, Leonardo ; Zur Linden, Alex ; Gardhouse, Sara ; Beaufrère, Hugues Takahashi, NobuyukiPloS one, 2023-02, Vol.18 (2), p.e0274060-e0274060 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Gemfibrozil improves lipid metabolism in Nile tilapia Oreochromis niloticus fed a high-carbohydrate diet through peroxisome proliferator activated receptor-α activationLuo, Yuan ; Hu, Chun-Ting ; Qiao, Fang ; Wang, Xiao-Dan ; Qin, Jian G. ; Du, Zhen-Yu ; Chen, Li-QiaoGeneral and comparative endocrinology, 2020-09, Vol.296, p.113537, Article 113537 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and GemfibrozilShitara, Yoshihisa ; Hirano, Masaru ; Sato, Hitoshi ; Sugiyama, YuichiThe Journal of pharmacology and experimental therapeutics, 2004-10, Vol.311 (1), p.228-236 [Periódico revisado por pares]United States: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |